Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Bereavement During a Course of TMS for MDD: A Case Report
1
x
$
30.00
Alexander Neumeister, MD: Tryptophan Depletion, Serotonin, and Depression: Where Do We Stand?
1
x
$
30.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
View Cart
Checkout
Home
Zonisamide for Bipolar Depression by Deborah Dauphinais
“Quetiapine XR Negative Clinical Trials Report by Gang Wang” has been added to your cart.
View cart
Zonisamide for Bipolar Depression by Deborah Dauphinais
$
30.00
Zonisamide for Bipolar Depression by Deborah Dauphinais quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-44-2-dauphinais
Categories:
Psychopharmacology Bulletin
,
VOL 44 No. 2 Articles
Tags:
adjunctive-treatment
,
bipolar-disorder
,
deborah-dauphinais
,
joshua-rosenthal
,
mark-polanski
,
medworks-media
,
michael-knable
,
mood-disorder
,
mood-stabilizer
,
no-2
,
norman-rosenthal
,
psychopharmacology-bulletin
,
treatment-efficacy
,
volume-44
Description
Description
ORIGINAL RESEARCH
Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial
Deborah Dauphinais, Michael Knable, Joshua Rosenthal, Mark Polanski, Norman Rosenthal
PB-44-2-2011-Dauphinais
Related products
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Page load link
Go to Top
